Akba stock price forecast institutional research desks cite akba

Institutional research desks cite akba stock price forecast upside if the firm secures strategic partnerships. M&A activity in the sector could act as a valuation driver. Meanwhile, institutions make up 43% of the company’s shareholders. Institutions will often hold stock in bigger companies, and we expect to see insiders owning a noticeable percentage of the smaller ones. Estimates for Lilly’s 2024 earnings have risen from $13.76 to $15.77 per share over the past 30 days. For 2025, earnings estimates have risen from $19.44 to $22.79 per share over the same timeframe. Year to date, Lilly’s stock has risen 63.5%. Some biotech traders see akba stock price forecast ranges tightening as institutional interest picks up. With cash burn under control and R&D milestones approaching, the equity could test resistance near $1.